Francis Collins, head of the US National Institutes of Health, said the coronavirus vaccine, developed by experts, could not be registered until November.
Potential candidates for the COVID-19 vaccine will not receive official approval until November or December this year, Qadin.Net reports quoting Reuters. According to Collins, the reason the vaccine will not be released to the public soon is because experts plan to continue large-scale clinical trials of the vaccine and measure its safety. He added that about 10,000 volunteers will be required for the study. This phase of testing will provide information on the safety and effectiveness of anti-infective drugs.
US President Donald Trump has announced that the American vaccine could be introduced on or before the November 3 presidential election.
In addition, the United States has refused to help Russia develop a vaccine against coronavirus infection. This was reported by CNN, citing unnamed Russian officials. It is noted that Moscow offered Washington cooperation in the framework of the Supersonic Speed program. According to the channel, the Russian Federation has been as open as possible to the exchange of experience, which allows the production of Russian vaccines in the United States. But the United States has been reluctant to take advantage of Russian medical advances.
It should be noted that the world's first registered Russian vaccine against coronavirus will be produced in Brazil.